Several studies have also reported that, in various cancers such as glioblastoma, acute myelogenous leukemia and prostate cancers CSCs, both canonical and non-canonical NF-κB signaling contribute to tumor growth and metastasis [11,12,13]. This evidence concerns the gene NFKB1 and glioblastoma.